Bank of New York Mellon Corp - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$5,342,000
+105.5%
304,203
+13.6%
0.00%0.0%
Q2 2021$2,599,000
+1783.3%
267,902
+2347.5%
0.00%
Q4 2015$138,000
-2.1%
10,946
+1.3%
0.00%
Q3 2015$141,00010,8030.00%
Other shareholders

There were no reported owners of TRILLIUM THERAPEUTICS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of TRILLIUM THERAPEUTICS INC shareholders